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Abstract
Multipotent stem cells (SCs) could substitute damaged cells and also rescue degeneration through the secretion of trophic
factors able to activate the endogenous SC compartment. Therefore, fetal SCs, characterized by high proliferation rate and
devoid of ethical concern, appear promising candidate, particularly for the treatment of neurodegenerative diseases. Super
Paramagnetic Iron Oxide nanoparticles (SPIOn), routinely used for pre-clinical cell imaging and already approved for clinical
practice, allow tracking of transplanted SCs and characterization of their fate within the host tissue, when combined with
Magnetic Resonance Imaging (MRI). In this work we investigated how SPIOn could influence cell migration after
internalization in two fetal SC populations: human amniotic fluid and chorial villi SCs were labeled with SPIOn and their
motility was evaluated. We found that SPIOn loading significantly reduced SC movements without increasing production of
Reactive Oxygen Species (ROS). Moreover, motility impairment was directly proportional to the amount of loaded SPIOn
while a chemoattractant-induced recovery was obtained by increasing serum levels. Interestingly, the migration rate of
SPIOn labeled cells was also significantly influenced by a degenerative surrounding. In conclusion, this work highlights how
SPIOn labeling affects SC motility in vitro in a dose-dependent manner, shedding the light on an important parameter for
the creation of clinical protocols. Establishment of an optimal SPIOn dose that enables both a good visualization of grafted
cells by MRI and the physiological migration rate is a main step in order to maximize the effects of SC therapy in both animal
models of neurodegeneration and clinical studies.
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Introduction
Nanomedicine has a leading role in pharmaceutical research
and development of clinical protocols, mainly in the form of
nanoparticle-based delivery systems for drugs and imaging agents,
especially in the field of stem cell (SC) therapies [1]. Several
functionalized nanoparticle formulations have been proposed for
medical applications, but few of them have been approved by the
Food and Drug Administration (FDA), mainly because of
reproducibility problems and uncertain stability in the long term
coupled to the absence of consensus guidelines on the required
biological testing [2,3].
Ferumoxides (a suspension of Super Paramagnetic Iron Oxide
nanoparticles (SPIOn)), are (FDA)-approved agents which may be
accurately, sensitively and easily detectable by non-invasive
Magnetic Resonance Imaging (MRI) to monitor grafted cell
distribution over time [4]. SPIOns consist of a coated iron oxide
core with an overall size greater than 50 nm (coating included)
and could potentially be modified for the creation of a
personalized nanomedicine tailored to patient- and disease-specific
needs [5]. Several reports have demonstrated the safety and
reliability of SPIOn labeling as a contrast agent transfer for SC
imaging/tracking [6] without apparent side effects on their
stemness (as reported by Balakumaran et al. [7] for bone marrow
mesenchymal cells). Nevertheless, an increasing number of recent
papers are challenging this perspective [8]. U.S. and European
governments are also promoting study programs on the impact of
nanotechnology and the potential risks of nanoparticles (United
States Enviromental Protection Agency (EPA), Nanotechnology &
Nanomaterials Research, http://www.epa.gov/nanoscience/
index.htm).
SPIOn molecular interactions may exert metabolic or muta-
genic effects on the surroundings, especially in the long term,
limiting their diagnostic and therapeutic potential [9]. A better
understanding of the behavior, collateral effects and toxicity of
SPIOn in complex biological fluids/conditions is therefore needed.
Alterations in migration capability are primarily involved in
pathological conditions (i.e. metastatic cancers, [10]) and are
essential in regenerative medicine (SC therapy, [11]).
Cell movements are finely regulated by Reactive Oxygen
Species (ROS) [12] which also play a pivotal role in maintaining
SC multipotentiality as well as in the progression of SC-associated
diseases [13,14] and/or cancer [15]. In the present study we
analyzed the possible interactions between (dextran-coated)
SPIOn loading, migration capability and time course production
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of ROS in two fetal SC populations, naı¨ve human chorial villi-
(hCVCs, collected between 10–12th weeks of pregnancy) and
amniotic fluid- (hAFCs, normally harvested around 15th weeks of
pregnancy) derived cells. hCVCs and hAFCs, conversely to
embryonic SCs, do not raise special ethical concerns. If compared
to adult SCs, they display higher multipotentiality and proliferative
capabilities, a low immunogenicity as well as an easy accessibility.
Moreover, they can be expanded in the long term without
tumorigenic risk [16]. These fetal SCs constitute alternative
interesting sources for cell therapies in neurodegenerative diseases.
As a matter of fact, the neurorescue potential and characteristics of
these fetal SCs have been extensively characterized by our group
[17].
Herein, we report that SPIOn loading, dose-dependently, affect
migration capability, but not ROS production in two fetal SC
populations, thus enlightening novel side effects of SPIOn labeling
and potential caveats for SPIOn application to (pre)clinical
therapy.
Materials and Methods
Cell Collection, Culture and Labeling
hAFCs and hCVCs were collected from amniotic fluid or
chorionic villi of pregnant women respectively, after specific
written informed consent for this research (approved by Institu-
tional Review Board and Ethical Committee of IRCCS-Istituto
Auxologico Italiano as 23C106, NP-FSC on April, 12, 2011,
following the Italian Law on Stem Cell Research, Senato della
Repubblica, Risoluzione (6-00004) (19 luglio 2006) n. 4).
Cells were isolated and grown in Amniomax II (Invitrogen,
Carlsbad, CA, USA) at 37uC and 5% CO2 in a fully humidified
atmosphere for one week before fetal karyotypization by standard
procedures (QFQ banding technique) [18,19]. After cytogenetic
analysis, exceeding cultures from pregnancies with a normal fetal
karyotype were used for research purpose, as specified in the
informed consent. To overcome any possible age-, donor- or sex-
related variation, we pooled together 4 different fetal donors (2
with a 46,XX and 2 with 46,XY karyotype) from women between
15–17th gestational week for hAFCs and 4 (2 with a 46,XX and 2
with 46,XY karyotype) from women between 11–13th gestational
weeks for hCVCs.
Cells obtained from every sample were harvested after gentle
trypsinization, centrifuged at 1,0006g for 10 minutes, pooled
together and counted. Dividing cells in suspension were collected
as well. Pools were then frozen (600,000 cells/aliquot) and stored
in liquid nitrogen. A periodic monitoring of karyotype was
conducted to check if subculturing has altered chromosome
constitution. hAFCs and hCVCs were loaded with the commer-
cially available MRI agent, dextran coated SPIOn (EndoremH;
AMI-25; 11,2 mg Fe/ml, Guerbet, Roissy, France, gently
provided by Dr. Bigini) coupled to Poly-L.Lysine (PLL, Sigma
Aldrich St. Louis, MO, USA) in Amniomax II, to maximize cell
internalization, as already described [20]. In this study, different
concentrations and different incubation times were chosen, as
specified below for each experiment while PLL concentration was
always maintained constant (see Table S1 in File S1).
To specifically verify SPIOn influence on the main biological
processes (proliferation, metabolism and migration) which affect
the therapeutic potential of SCs we sequentially analyzed them.
Proliferation Assays
Cell proliferation was performed on 75,000 cells/well in
untreated 12-wells plate (NUNC) and each sample was tested in
quadruplicate. Cells after SPIOn loading for 72 hrs, were cultured
for around 3 weeks, with weekly medium change. At different time
points, as detailed in the corresponding graphic, cells were
detached and counted (Fig. 1a). Briefly, cells were centrifuged at
1,0006g for 10 min and suspended in 500 ml of fresh medium.
Cell viability was assayed at each experimental time point using
the Trypan blue exclusion method (Sigma-Aldrich) on an aliquot
(10 ml) of each sample.
Assay of Cell Metabolism
Cell metabolism is deeply influenced by intra-cellular and extra-
cellular conditions with potential implications on cell migration,
therefore we tested if our experimental conditions (presence of
increasing SPIOn doses or 6-hydroxydopamine (6-OHDA)) may
affect this biological parameter.
Basal metabolism. Cell viability was evaluated by (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophe-
nyl)-2H-tetrazolium, inner salt) MTS assay (CellTilter 96H
AQueous Assay, Promega, Madison, WI, USA) following manu-
facturer’s instructions. To test the potential toxicity of SPIOn, first
hAFCs and hCVCs were loaded with increasing concentrations of
SPIOn (0 (control, CTR), 5, 10, 25 and 35 mg/ml) for 72 hours, as
detailed in the corresponding figure. Cells were then collected and
plated (50,000 cells/well) in 96-well plates (NUNC). One hour
after a resting time at 37uC, MTS solution (20 ml/well) was added
and cells were incubated for another hour at 37uC. The
supernatant of cell cultures was collected, centrifuged at
2,0006g for 5 minutes and read at 490 nm with a microplate
reader (Elx800, Bio-Tek Instruments Inc., Winooski, VT, USA).
Results were expressed as a percentage of viable cells versus CTR
(unlabeled cells) using the following function: ‘‘labeled cells
value’’61004‘‘unlabeled cells value’’.
Effect of 6-OHDA exposure on metabolism. Toxicity of 6-
OHDA was also assessed on both unlabeled and SPIOn labeled
(35 mg/ml, 72 hours of incubation) hAFCs and hCVCs (50,000
cells/well in 96-well plates, NUNC). SH-SY5Y was used as
positive control: this is a cell line subcloned from a bone marrow
biopsy of a patient affected by a neuroblastoma. SH-SY5Y cells
are susceptible to 6-OHDA and therefore represent a good
positive control to test the effect of this neurotoxin. Cells were
plated and placed at 37uC for 1 hour before being treated with 6-
OHDA (100 mM, as previously published, [17]). Survival was
measured 1, 4 and 6 hours after exposure to the toxin by adding
MTS solution as described above.
Results were expressed as a percentage of viable cells versus
CTR (not treated cells), as detailed before.
Migration Assay
This assay employs a simplified Boyden chamber-like design
that consists of two chambers separated by a filter coated with
different extra-cellular matrix components. The cell suspension is
placed in the top chamber and incubated in the presence of test
media eventually containing specific chemoattractants in the
bottom chamber. Cells migrate from the top chamber through the
coated filter pores to the bottom of the filter. Detection of cell
invasion is quantified using calcein acetoxymethyl ester (calcein-
AM). Cell dissociation/Calcein-AM solution is placed in the
bottom chamber to dissociate the migrating cells from the filter.
Calcein-AM is internalized by the cells, and intra-cellular esterases
cleave the acetomethylester moiety. Free Calcein fluoresces
brightly and is used to quantify the number of cells that have
invaded or migrated by comparison with a standard curve.
Migration capability of hAFCs and hCVCs was evaluated by a
Cultrex 96 Well Cell Migration Assay kit (Trevigen, Gaithersburg,
MD, USA) following manufacturer’s instructions. Briefly, hAFCs
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and hCVCs were loaded with 0 (control, CTR), 5, 10, 25, 35 mg/
ml of SPIOn at time T0 (T indicates here the number of days after
SPIOn addition, see Fig. 1c) as described before. Twenty-four
hours before migration assay (T3), Amniomax II was replaced with
serum free MEM (Gibco Invitrogen). The day after the end of
SPIOn incubation (T4 from the beginning of the experiment)
hAFCs and hCVCs were collected, resuspended in MEM, plated
(50,000 cells/well) in the upper chamber of the specific 96-well
plate provided by the manufacturer and placed at 37uC for 48
hours. At T6 migrated cells were quantified as described in
manufacturer’s instructions (further details for each experiment
design are reported in the corresponding figures). For additional
details on all the experimental procedures see Table S2 in File S1.
Additionally in same experiments, to test how hAFC and hCVC
migration was influenced by the addition of a chemoattractant
(fetal bovine serum (FBS, Sigma Aldrich)), the bottom chamber
was loaded with serum free media or with 10, 20 or 30% FBS
respectively.
We also mimicked a pathophysiological condition with a well
standardized cell model of neurodegeneration to observe any
eventual influences of SPIOn presence on cell migration in this
experimental setting. Presently, cell models for neurodegenerative
diseases, (i.e. Parkinson’s disease (PD)) primarily include neuronal
tumor cell lines, such as the human neuroblastoma cells (SH-
SY5Y). These cells mimic many aspects of the dopaminergic
neuron death observed in PD in a well standardized way, when
treated by neurotoxins such as 1-methyl-4-phenyl-pyridinium
(MPP+), 6-OHDA, or rotenone without the high variable response
of primary dopaminergic cultures derived from different brain
regions, after the addition of 6-OHDA [21]. Therefore, in a
further experimental setting, we checked if SPIOn labeled cell
motility could be affected by the ongoing degeneration of the
neighboring cells: we plated the SH-SY5Y cells (50,000 cells/well)
cells in the bottom chamber at T3 (as detailed in the
corresponding figure and in Table S2 in File S1). The following
day (T4), SH-SY5Y cells were challenged with serum free MEM
plus 6-OHDA 100 mM dissolved in saline solution containing
0.02% ascorbic acid (both provided by Sigma Aldrich), while
unlabeled cells (used as control, CTR) or SPIOn labeled hAFCs
and hCVCs were plated in the upper chamber as described before.
Figure 1. Evaluation of SPIOn labeled cell biological properties and migration. a Proliferative and b metabolic rates of hCVCs appeared not
affected by SPIOn presence, as previously demonstrated by our group for hAFCs [20]; c hAFCs and hCVCs were incubated for 72 hours with SPIOn
(35 mg/ml) and then migration assay was performed. Data are expressed as a percentage of migrated cells. ***p,0.001 versus respective (unlabeled,
control cells, CTR); uup,0.01 versus SPIOn labeled hCVCs. One way analysis of variance (ANOVA) as specified in the statistical section.
doi:10.1371/journal.pone.0078435.g001
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Migration capability of cells toward the degenerating model was
assessed 1, 4 and 6 hours after 6-OHDA exposure. In every
experiment, results were expressed as a percentage of migrated
cells.
Staining Procedures for Iron Presence
Evaluation of the internalization of SPIOn in hAFCs and
hCVCs was performed by Prussian Blue staining (which labels iron
deposits) using a diagnostic kit specific for the detection of ferric
iron overload in cells and tissue (PERLS, BioOptica, Milan, Italy).
Prussian blue reaction involves the treatment of sections with acid
solutions of ferrocyanides. Any ferric ion (+3) present in the tissue
combines with the ferrocyanide and results in the formation of a
bright blue pigment called Prussian blue, or ferric ferrocyanide.
This is one of the most sensitive histochemical tests and will
demonstrate even single granules of iron in cells. Labeled cells
were rinsed with Phosphate Buffered Saline (PBS, pH 7.2 Sigma
Aldrich), collected after trypsinization, plated in 24-well plate, at a
density of 30,000 cells/well on glass coverslips and cultured at
37uC with 5% CO2 until adhesion. SCs were then fixed with 4%
paraformaldehyde (w/v, in 0,1 M PBS) for 20 minutes. Following
manufacturer’s instructions, after several washings with distilled
water, SCs were incubated 20 minutes with a mixture of reagent
ATM and reagent BTM (1:2.5 v/v in distilled water, provided with
the kit) then washed with distilled water. All the passages were
done at RT. Coverslips were mounted on microscope slides,
observed and images were acquired with a CCD camera, directly
connected with a Leica DMRS/HCS (Wetzlar, Germany)
microscope.
Intra-cellular ROS Measurement
For analysis of intra-cellular ROS, hAFCs and hCVCs were
labeled with the oxidation-sensitive probe 29,79-dichlorodihydro-
fluorescein diacetate (DAF-FM, Molecular Probes, Invitrogen).
Briefly, the day before the experiment, cells were plated in a
Fluorometer/Luminometer white 96-well plates (NUNC, Roche-
ster, NY USA; 50,000 cells/well) and left overnight at 37uC to
allow adhesion. Cells were then incubated with DAF-FM (5 mM)
for 15 minutes in the specific buffer (150 mM NaCl, 3 mM KCl,
20 mM HEPES, 10 mM Glucose, pH 7,4, 2 mM CaCl2?6 H2O,
1 mM MgCl2?6 H2O), washed and incubated for 72 hours with
SPIOn (35 and 100 mg/ml in buffer). Fluorescence was measured
both during incubation with SPIOn (from 1 to 5 hours, two
different concentrations 35 and 100 mg/ml; 6–72 hours only
35 mg/ml) and after SPIOn removal (concentration 35 mg/ml, 12,
24, 48 and 72 hours) by a microplate reader (Fluoroskan Ascent
FL, Thermo Labsystems, Vantaa, Finland. Reading parameters:
ex = 485 nm, em=530 nm). Thereafter, values were correlated to
cell viability measured by digitonin (160 mM, Sigma Aldrich) and
propidium iodide (PI, 50 mM, Sigma Aldrich) exposure for 20
minutes at 37uC and subsequent reading with the same instrument
(Reading parameters: ex = 530 nm, em=590 nm) [22]. To avoid
misinterpretations, data were normalized on the number of cells in
the corresponding well.
Flow Cytometric Analysis and Fluorescence Imaging
To simultaneously compare their naı¨ve dimension, hCVCs and
hAFCs were separately labeled with two different fluorescent dyes
(PKH26 Red Fluorescent-, for hCVCs, and PKH67 Green
Fluorescent- for hAFCs, Cell Linker Kit; Sigma Aldrich) as
previously reported [23]. To confirm our data and to exclude any
possible influence of light absorbance/emission, the fluorescent
probes were also exchanged between the fetal SC types, using the
PKH26 Red linker for hAFCs, and PKH67 Green linker for
hCVCs. These fluorescent cell linkers can incorporate a fluores-
cent dye into lipid regions of the cell membranes, that may be
detectable by flow cytometric analysis.
Cells (300,000 cells/sample) were mixed immediately before
flow cytometric analysis, but they remained easily distinguishable
by their excitation and emission spectra (respectively phycoery-
thrin and fluorescein). Samples were acquired after lysis by a flow
cytometer (FACSCanto II Becton Dickinson) and analyzed using
the dedicated Diva software. All possible combinations of the
fluorescent dyes were used in order to validate our results in
triplicate.
Labeled cells were also observed by fluorescent microscopy to
confirm flow cytometry data on a confocal microscope (Nikon
Eclipse Ti, Japan).
Intra-cellular Fe Measurement
Elemental analysis was carried out by inductively coupled
plasma optical emission spectrometry (ICP-OES analysis) using an
Optima model 8300 instrument (Perkin Elmer, Waltham, MA).
Samples were analyzed after digestion using concentrated nitric
acid (Sigma Aldrich).
Statistics
Each experiment was run in triplicate on 5–6 different pools
with at least three replicates for each condition and representative
values were expressed as mean 6 SD.
Data were analyzed using one or two way analysis of variance
(ANOVA) followed by Bonferroni post hoc test (as specified in the
respective figure or table), using a dedicated statistical software
(GraphPad Prism, Inc., La Jolla, CA, USA).
Results
Preservation of Biological Properties in hCVCs Incubated
with SPIOn
Here we demonstrated here that SPIOn internalization (35 mg/
ml for 72 hours) did not significantly alter proliferation,
metabolism and morphology of hCVCs in vitro (Fig. 1 a, b).
Indeed, no significant differences were found in the number of
cells in culture at different time points (T0, T3, T6 T10 and T13)
between loaded and unloaded hCVCs, demonstrating that SPIOn
did not altered the cell growth rate (Fig. 1 a). Similarly, the
percentage of viable cells was comparable until T13 indicating that
metabolic rate of hCVCs appeared not affected by SPIOn
presence (Fig. 1 b).
SPIOn Influenced Migration of hAFCs/hCVCs without
Increasing Intra-cellular ROS
In our experimental conditions, we found that hAFCs and
hCVCs (labeled with SPIOn 35 mg/ml for 72 hours) did not
shown morphological differences, but a significant reduction of
migration capability, when compared with unlabeled cells (CTR).
Migration rate of loaded cells was approximately halved in respect
to CTR (Fig. 1c).
Excess ROS are generated during a variety of cell stresses and
may contribute to inflammation and cell/tissue damage. There-
fore, to check if SPIOn internalization in cells in these conditions
could interfere with physiological cell processes, we measured the
ROS formation at different time points during incubation and
after SPIOn removal (see experimental scheme Fig. 2). We
observed that there were no significant differences in ROS
production between unlabeled (CTR) and SPIOn-labeled hAFCs
and hCVCs during SPIOn incubation (35 mg/ml from 1 to 5
Novel Side Effect of SPIOn Labeling in Stem Cells
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hours) (Fig. 2a and b, respectively). On the other hand, cells
labeled with a maximal dose of SPIOn (100 mg/ml for 72 hours),
displayed statistically significant augment of fluorescence intensity
at every considered time point if compared to both control (CTR)
and 35 mg/ml condition (Fig. 2a and b). Increase of intra-cellular
ROS formation is therefore influenced by SPIOn amount.
Between 6 and 24 hours of SPIOn loading (35 mg/ml for 72
hours) the level of intra-cellular ROS was unaffected and
comparable between CTR and SPIOn labeled cells for the first
24 hours (Fig. 2c and d). Fluorescence intensity was significantly
enhanced at 48 and 72 hours during SPIOn internalization in
respect to previous incubation times for both unlabeled-control
(CTR) and labeled SCs, but no significant differences were
observed between CTR and labeled hAFCs or hCVCs (Fig. 2c
and d, respectively). We also checked ROS formation during a
time course after SPIOn removal (from 6 to 72 hrs later) in serum-
free medium: interestingly, no statistical differences between CTR
and SPIOn loaded cells were observed. Moreover, the level of
intra-cellular ROS produced by hCVCs was significant lower than
hAFCs during the first 48 hrs (Fig. 2 e–h). This difference
disappeared 72 hours after SPIOn removal: at this time point
fluorescence intensities of the two cell populations were compa-
rable (Fig. 2i).
Figure 2. Evaluation of intra-cellular ROS during internalization and subsequent removal of SPIOn. a hAFCs and b hCVCs were plated
and labeled with DAF-FM to visualize intra-cellular ROS, before being incubated with SPIOn (35 or 100 mg/ml). ROS measurement was performed
every hour (from 1st to 5th) during SPIOn internalization (see experimental scheme). Data are expressed as ROS fluorescent signal normalized for
Digitonin-PI. Unlabeled cells represent control condition (CTR). No statistically significant differences were observed between CTR and SPIOn labeled
cells. ***p,0.001 versus CTR; uuup,0.001 versus SPIOn (35 mg/ml). Two way analysis of variance (ANOVA); c hAFCs and d hCVCs were plated and
labeled with DAF-FM and then were incubated with SPIOn (35 mg/ml). ROS evaluation was done at different time (6, 12, 24, 48 and 72 hours) after
SPIOn addition. Data are expressed as ROS fluorescent signal normalized for Digitonin-PI. Unlabeled cells represent control condition (CTR).
***p,0.001 versus respective 6 hours; uuup,0.001 respective 12 hours; +++p,0.001 versus respective 24 hours. Two way analysis of variance
(ANOVA) as specified in the Statistical section. To better visualize the significant difference in intra-cellular ROS formation between hAFCs and hCVCs,
we compared the two cellular groups at e 6, f 12, g 24, h 48 and i 72 hours after SPIOn removal. Data are expressed as ROS fluorescent signal
normalized for Digitonin-PI. Unlabeled cells represent control condition (CTR). **p,0.01 and ***p,0.001 versus hAFCs. Two way analysis of variance
(ANOVA), as specified in the statistical section.
doi:10.1371/journal.pone.0078435.g002
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Migration Rate of hAFCs an hCVCs is Dose Dependently
Influenced by SPIOn Presence
In a second set of migration experiments, we wanted to verify if
impairment of cellular motility in our system was due to the
concentration of SPIOn used. The same experiments were
performed with decreasing concentration of the nanoparticles
(from 35 to 5 mg/ml). We observed a progressive significant
recovery of migration, inversely proportional to SPIOn concen-
tration. Graph reported in Fig. 3a clearly illustrates that, starting
from SPIOn concentration of 25 mg/ml, there is a significant
increase in SPIOn-labeled cell migration, until no more differences
were retrieved between unlabeled cells (CTR) and hAFCs or
hCVCs labeled with 5 mg/ml SPIOn for 72 hours. Indeed, if
compared to unlabeled cells, only about 50% of both SPIOn
labeled (35 mg/ml) hCVCs and hAFCs migrated. However, when
decreasing the concentration of SPIOn labeling to 5 mg/ml, the
rate of migration was completely recovered.
MTS assay was performed to check cell survival under every
condition and ascertain that reduced cell migration was not due to
hAFC and hCVC death. We observed no significant differences in
hAFC and hCVC viability, even when the higher concentration of
SPIOn was used (35 mg/ml; Fig. 3b).
Naı¨ve hAFCs and hCVCs have Similar Dimension and
Internalized the same amount of SPIOn
During migration experiments we observed that SPIOn-labeled
hAFCs displayed a reduced motility if compared to hCVCs
(24.865.2 vs 30.268.8, uup,0.01 versus SPIOn labeled hCVCs)
in the same experimental conditions (Fig. 1c). This discrepancy
could be either due to different cell dimensions or to different
SPIOn uptake between the two SC populations, so we verified any
eventual variations of these parameters in our experimental
settings.
Figure 3. Migration and survival of hAFCs and hCVCs labeled with different SPIOn concentrations. a Cells were labeled with different
concentration of SPIOn for 72 hours before migration assay. Data are expressed as a percentage of migrated cells. *p,0.05, **p,0.01 and
***p,0.001 versus respective CTR (control, unlabeled cells). Two way analysis of variance (ANOVA); as specified in the statistical section; b hAFCs and
hCVCs labeled with different SPIOn concentrations were used to test SPIOn toxicity by MTS assay. Data are expressed as a percentage of viable cells
versus unlabeled cells used as control (CTR). Two way analysis of variance (ANOVA); as specified in the statistical section.
doi:10.1371/journal.pone.0078435.g003
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Each naı¨ve cell type was loaded with the same amount of
SPIOn (35 mg/ml) for 72 hours and separately labeled with a
specific fluorescent membrane linker (PKH26 Red for hAFCs and
PKH67 Green for hCVCs, then the two linkers were switched
between the SC types to validate the retrieved data). The two cell
types were then mixed for FACS analysis (see experimental
paradigm in Fig. 4) to exclude cell size differences since bigger cells
have higher surface, higher iron uptake and then lower migration
rate.
No difference between the cell sizes was detected, as shown in
the representative graphics of Figure 4 depicting single populations
(Fig. 4 a,b CTR; Fig. 4 d,e; Fig. 4 g,h), or analysis on the mixed
population (Fig. 4c,f and confocal image in Figure S1). Moreover,
we quantified the amount of SPIOn loaded in hAFCs and hCVCs
after different internalization times. ICP-OES analysis reported in
Table 1 showed that the iron content in both samples (hAFCs and
hCVCs) increases during the 72 hours incubation from a negligible
amount to a bit more than 1 ppm. Therefore, the time-dependent
uptake of SPIOn in our samples directly corresponded to the
measurable amount of intra-cellular iron. Moreover, our analysis
confirmed that the two cellular types internalized a similar
concentration of SPIOn, at every time point considered (24, 48
and 72 hours of SPIOn internalization; see Table 1).
Altogether our data demonstrate that the two naı¨ve populations
had the same size and iron uptake thus excluding that the retrieved
differences in migration between the two cell types are not related
to these parameters.
The Presence of Serum could Partially Restores the
Physiological Migration Rate in SPIOn Labeled Cells
To check if in our experimental condition the chemoattractive
property of serum is able to restore physiological migratory
properties of SPIOn-labeled cells (concentrations from 5 to 35 mg/
ml), medium with 10% FBS was added in the bottom chamber, as
detailed in the experimental design, Fig. 5. We observed a
significant increase of migration rate for both unlabeled (CTR)
and SPIOn labeled cells: this effect was detected for both hAFCs
and hCVCs independently from SPIOn concentrations (Fig. 5 a
and b, respectively). Starting from SPIOn concentrations of
25 mg/ml, comparable migratory properties between CTR and
SPIOn loaded cells were retrieved by the addition of 10%FBS.
We also investigated if increasing percentages of FBS (10,20 or
30% FBS) could dose-dependently restore migration in SPIOn-
labeled cells (35 mg/ml for 72 hours), as detailed in the
experimental design, Fig. 5. A strong enhancement of cellular
migration was found in every considered condition, even in CTR
samples. Interestingly, both SPIOn labeled hAFCs and hCVCs
displayed a significant increase of migrated cells in presence of
30% FBS (Fig. 5c and d, respectively). In this condition indeed, the
percentage of SPIOn labeled migrated cells resembled the
unlabeled (CTR) one (80%63.104 CTR and 62%61 SPIOn
loaded hAFCs; 83%63.062 CTR and 71%61.741 SPIOn loaded
hCVCs).
Neurodegenerative Surroundings Influence the
Migration Rate of SPIOn Labeled Cells
SC rate of migration is strongly influenced by the surroundings:
their movements can be stimulated by soluble factors (chemotactic
signals) released by damaged cells or tissues. To observe if a
lesioned environment may influence migration of SPIOn loaded
hAFCs and hCVCs we exploited SH-SY5Y cell line exposed to 6-
OHDA, as a well standardized model of cell neurodegeneration.
First we checked the sensitivity to 6-OHDA for all our cell types.
SH-SY5Y, hAFCs and hCVCs were plated and treated with 6-
OHDA (100 mM). By MTS assay, viability was then tested after 1,
4 or 6 hours of exposition to the toxin. We found that SH-SY5Y
survival was significantly reduced starting from 4 hours after 6-
OHDA exposure (Fig. 6a). On the other hand, MTS assay
performed on 6-OHDA-treated hAFCs and hCVCs revealed that
the metabolic rate of these cells remained unaffected by the
neurotoxin presence (Fig. 6b and c, respectively).
Thereafter, we performed a migration assay plating SH-SY5Y
on the bottom chamber while unlabeled (CTR) and SPIOn-
labeled hAFCs and hCVCs were seeded in the upper chamber, as
illustrated in Fig. 6d and Table S2. The number of migrated cells
measured at different times after SH-SY5Y 6-OHDA exposure
revealed that, in presence of ongoing degeneration, SPIOn labeled
hAFCs and hCVCs could increase their migration rate (Fig. 6e
and f, respectively). Interestingly, migration was time dependently
enhanced by SH-SY5Y 6-OHDA treatment in all experimental
conditions (Fig. 6e and f).
Discussion
Molecular medicine imaging is a recent biomedical approach
that allows the non invasive in vivo characterization of cell
biological processes over time, especially in SC therapy [24].
Several subtypes of inorganic nanoparticles have been developed,
as a contrast agent, leading to their safe application in different
fields, from drug delivery in cancer therapy [25] to (pre) clinical
dynamic imaging of transplanted SCs [1]. SPIOn coupled to PLL
can be easily and safely internalized in several cell types and
tracked in animals by MRI imaging after grafting [20,26]. Biology
and physiology of human embryonic stem cells are not affected by
SPIOn labeling (concentration 50 mg/ml for 24 hours) maintain-
ing a persistent signal during long term MRI imaging (21 days)
[27].
Recently, it has been reported that implanted SPIOn patches
(with an iron concentration of 552 mg/ml) in animals can undergo
slow progressive degradation in vivo over time [28], thus potentially
interfering with cell physiology, mainly in relation to macrophage
activation and presence of multinucleated giant cells. A possible
pro-inflammatory and allergenic property of SPIOn has been
suggested after single intra-tracheal administration of SPIOn at
different concentrations in mice [29]. Several additional potential
side effects of SPIOn labeling (i.e. membrane leakage of lactate
dehydrogenase, impaired mitochondrial function, inflammation,
apoptosis and DNA damage) have been summarized by Singh
et al [8].
Our data indicate that SPIOn labeling dose-dependently affect
human fetal SCs in vitro confirming a previous report on altered
migration rate of neural progenitor cells loaded with SPIOn in vivo
[30]. The reported novel collateral in vitro effects of SPIOn
presence in human fetal SCs may therefore negatively influence
the outcomes of SPIOn loaded cells in clinical regenerative
protocols.
In this study we used a limited dose of SPIOn (35 mg/ml for 72
hours) that has no collateral effect and is safe on the most
important biological properties of hCVCs in vitro (as presented
here) and hAFCs both in vitro and in vivo [20]. As a matter of fact,
we have previously characterized the stem and therapeutic
potentials of both hAFCs and hCVCs [17] analyzing in details
the safety, efficiency and reliability of two different tracers (SPIOn
and Hoechst 33258) for the imaging of hAFCs in vitro, in vivo and ex
vivo [20]. We also observed the in vivo survival of SPIOn loaded
hAFCs, till 56 days after transplantation, in the lateral ventricles of
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Figure 4. Flow cytometric analysis. Fluorescent cell linker labeled hCVCs (here PKH26) and hAFCs (here PKH67) were analyzed by flow cytometry
in order to investigate differences in size and cell complexity. Representative figure of unlabeled hCVCs and hAFCs (a,b): when they were mixed, a
single cell population was detected (c); different labeling of hCVCs (d,g) and hAFCs (e,h), before mixing the cells, allowed us to identify
simultaneously both the cell population confirming their comparable size and complexity (f).
doi:10.1371/journal.pone.0078435.g004
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wobbler mice (an animal model of amyotrophic lateral sclerosis)
jointed to the long-term permanence of grafted cells even in
damaged areas demonstrating the usability of these SPIOn labeled
cells in animal models of neurodegeneration [20].
Nevertheless, we observed an enhanced ROS production, after
48 hours of SPIOn loading at low dose, without reaching statistical
significance for both SC types with respect to controls. ROS
production was lower in hCVCs than in hAFCs at any time point
considered, although comparable cell size and iron uptake were
demonstrated in both fetal SCs over time. Moreover, in our
experimental conditions, SPIOn loaded hCVCs displayed lower
ROS production, at least until 48 hours after SPIOn removal.
Similar ROS levels were observed after 72 hours in serum free
medium for both SC types, while only 9–12 hours are required in
human embryo kidney (HEK 293) and HeLa cervix carcinoma
cells to observe major ROS-induced apoptotic cell death triggered
by withdrawal of cell survival factors [31]. Concordantly to our
data, the level of antioxidant defense necessary for maintaining SC
identity appears developmentally regulated and decreases along
differentiation [15] since SC metabolism and potential appear
directly connected to redox homeostasis [14].
Our data also show that the higher dose of SPIOn loading
(100 ug/ml, well known in literature to cause an important
increase of ROS formation [32]) produces substantial ROS
Table 1. Intra-cellular ferric ions measurement.
hAFC hCVC
CTR 0.02560.01 0.03560.01
24 hours 0.45560.11 0.55060.13
48 hours 0.55060.13 0.70560.16
72 hours 1.31060.30 1.67060.38
Cells were incubated for 24, 48 or 72 hours with 35 mg/ml of SPIOn. Iron
content expressed as Fe and Fe3O4 in control-samples of AFC, CVC and
physiological solution along with a Fe3O4 standard at 35 ppm are reported.
Unlabeled cells represent control condition (CTR). Data (mg/L) are expressed as
mean 6 SD and analyzed with two way analysis of variance (ANOVA).
doi:10.1371/journal.pone.0078435.t001
Figure 5. Effect of serum concentration on the migration of SPIOn labeled hAFCs and hCVCs. a hAFCs and b hCVCs were incubated for
72 hours with different concentration of SPIOn and then migration assay was performed. In these experimental setting, medium with 10% FBS was
added in the bottom chamber. Data are expressed as a percentage of migrated cells. Unlabeled cells represent control condition (CTR). **p,0.01 and
***p,0.001 versus serum free medium. Two way analysis of variance (ANOVA) as specified in the Statistical section; c hAFCs and d hCVCs were
labeled with SPIOn 35 mg/ml (72 hours of incubation) and migration assay was performed. In these experiments medium plus 10, 20 or 30% FBS was
added in the bottom chamber. Data are expressed as a percentage of migrated cells. Unlabeled cells represent control condition (CTR). *p,0.05 and
***p,0.001 versus serum free medium. up,0.05 and uuup,0.001 versus 10% FBS; +p,0.05 and +++p,0.001 versus 20% FBS. Two way analysis of
variance (ANOVA) as specified in the statistical section.
doi:10.1371/journal.pone.0078435.g005
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increases in few hours while only longer SPIOn incubations at low
dose (48–72 hours) generate significant augment of intra-cellular
ROS levels in fetal SCs in respect to previous incubation times.
ROS generation, jointed to decreased cell proliferation, mito-
chondrial damage, apoptosis and autophagy, were also described
after higher SPIOn labeling (.50 mg/ml for 48 hours) in human
endothelial cells [33]. In our experimental conditions the
significant impaired rate of cell migration in SPIOn loaded cells
appears independent from the contemporaneous ROS increase
(comparable between control and treated cells), 72 hours after
SPIOn removal. Altogether our data, also supported by the
literature, suggest that the SPIOn loading time should not exceed
the 24 hours to guarantee the lowest ROS production, even at low
SPIOn concentration (35 mg/ml).
Migration is an essential process during cell life in organism
from development to ageing [34], but even more a well organized
collective migration towards damage areas is fundamental for
tissue regeneration in cell therapy, as already demonstrated for
neurodegenerative diseases and brain tumors [35,36]. Previous
studies have demonstrated that SPIOn labeling may, dose-
dependently, affect the intra-cellular actin cytoskeleton and
microtubule architecture, until iron content is eluted by cell
division [37,38]. We previously demonstrated by transmission
electron microscopy that the SPIOn concentration used here did
not alter the cytoplasmic ultrastructure of hAFCs [20]. Neverthe-
less, here we retrieved a dose-dependently reduced migration rate
of both SPIOn labeled SCs. Interestingly, our data showed that
migration impairment due to SPIOn loading in SCs may be at
least partially recovered by a chemoattractive (increasing FBS
doses) or an ongoing degenerative surrounding (such as SH-SY5Y
exposed to 6-OHDA [22]) thus demonstrating that the motility
remains physiologically influenced by the appropriate stimuli. This
Figure 6. Role of ongoing degeneration on cell migration. a SH-SY5Y cells were plated and treated with 6-OHDA 100 mM. After 1, 4 and 6
hours viability was measured by MTS assay. Data are expressed as a percentage of viable cells versus CTR (no 6-OHDA treated cells). ***p,0.001
versus CTR. One way analysis of variance (ANOVA) as specified in the Statistical section; b hAFCs and c hCVCs were incubated for 72 hours with SPIOn
(35 mg/ml) and then were treated with 6-OHDA (100 mM). MTS assay was performed 1, 4 and 6 hours after 6-OHDA/toxin addition. Data are expressed
as a percentage of viable cells versus respective CTR (no 6-OHDA treated cells). Two way analysis of variance (ANOVA) as specified in the Statistical
section. d timeline of migration experiments; e hAFCs and f hCVCs were labeled with SPIOn 35 mg/ml (72 hours of incubation) followed by the
migration assay. In these experiments, SH-SY5Y cells were plated in the bottom chamber and then treated with/exposed to 6-OHDA (100 mM).
Migration was evaluated 1, 4 and 6 hours after treatment. Data are expressed as a percentage of migrated cells. Unlabeled cells represent control
condition (CTR). ***p,0.001 versus not treated (NT) SH-SY5Y cells; up,0.05, uup,0.01 and uuup,0.001 versus 1 hour treatment; +++p,0.001 versus 4
hours treatment. Two way analysis of variance (ANOVA) as specified in the statistical section.
doi:10.1371/journal.pone.0078435.g006
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observation could therefore explain the qualitatively comparable
distribution of control and SPIOn labeled SCs after transplanta-
tion [30], even in a neurodegenerative environment [20].
Nevertheless, our data here demonstrates that only the lowest
concentration of SPIOn (5 mg/ml) guarantees a migration rate
comparable to controls. Concordantly, cell motility of neural SC
appeared reduced in vivo after SPIOn labeling (25 mg/ml for 24
hours), although a time dependent reduction of iron content by
exocytosis partially restored the physiological migration rate [30].
Cell invasion appeared also inhibited post SPIOn internalization
in human differentiated cells [39,40] while we report and quantify
here for the first time in vitro a reduced migration rate of human
SCs. We also speculate that only a careful choice of SPIOn dose
and the SC source could guarantee best imaging, physiological cell
migration rate and the correct assessment of the eventual
therapeutic effects, both in animal models and clinical applica-
tions.
The dose-dependent impairment of cell motility we describe
here, may therefore affect the outcomes of (pre)-clinical trials of
SPIOn loaded SCs, especially in a neurodegenerative/patholog-
ical environment where misregulation of metal homeostasis [41] or
iron accumulation [42] already play a critical role. A direct link
between excessive metal-induced oxidative stress and human
diseases have been demonstrated [43] suggesting that iron
chelation might be a promising therapeutics, at least in several
neurodegenerative diseases [44].
Moreover, diffuse neurotoxicity/multiple side effects of iron
nanoparticle have been described in several cell systems from
neuronal cell models to Central Nervous System (CNS) microglia
and primary neuronal cells. Intra-cellular delivery of even
moderate levels of iron oxide nanoparticles (iron concentration
from 0.15 to 15 mM) adversely affects cell functions of the rat
pheochromocytoma cell line (PC 12), an ideal model system for
the study of neural stem cell development and differentiation.
Multiple side-effects have been described: i) statistically significant
reductions in PC12 cell viability, coupled to significant cell
detachment, within the first 48 hours after nanoparticle loading; ii)
changes in morphology and cytoskeletal structure of cells after
differentiation into neuronal type cells post Nerve Growth Factor
exposure (100 ng/ml) with minimal axonal/microtubule sprouting
deprived of mature neurites and neuronal branching, dose
dependently correlated to the iron content; iii) significantly
diminished expression of the neuronal protein growth-associated
protein-43 associated with axonal growth, neuronal plasticity,
learning and development as well as physiological function of
neuronal system [45]. Concordantly, primary cultures of CNS
microglial cells have demonstrated clear-cut decreases in cell
viability starting from 20 mg/mL concentrations of paramagnetic
nanoparticles. Moreover, a differential iron uptake by microglial
cells has been observed in comparison to the surrounding brain
cells, thus potentially limiting efficient nanoparticle delivery to
mixed populations of neural cells, characterized by heterogeneous
kinetics of iron loading [46]. Similarly, uptake studies in primary
mixed neuronal/glial cultures from cerebellum have revealed
predominant uptake of magnetic nanoparticles (at concentration
of 50 mg/ml) by microglia and a significant increase in their
number. Conversely, in primary mixed Schwann cell/fibroblast
cultures it has been showed a comparable iron uptake, but a
decrease in the Schwann cell number after nanoparticle loading.
Active microglial phagocytosis, due to iron uptake, has been
reported in organotypic co-cultures of spinal cord slices and
peripheral nerve grafts suggesting also a potential metal-induced
immune system reactivity in vivo [47]. Viability of cultured
microglial cells and alterations in the membrane integrity have
been described compromised by 3 hour incubations with iron
concentrations of 450 or 1500 mM while the simple coating
material, in the absence of the iron oxide core, has not effect on
cell survival [48].
Our data may be also useful to efficiently calibrate the best
SPIOn content and incubation time to maximize beneficial effects
in cells preserving best imaging resolution, especially for novel
therapeutic approaches, such as the application of magnetic iron
nanoparticles to reduce the amyloid aggregates typical of
Parkinson’s, Alzheimer’s Disease and type II diabetes [49]. The
reported altered migration of SPIOn loaded SCs and the recovery
in a neurodegenerative environment appears particularly critical
in neurological diseases where tissue accessibility to the damaged
area could be precluded or harmful and therefore neurorescue
requires active migration.
Conclusion
Our data enlighten novel collateral effects of SPIOn presence in
human fetal SCs in vitro which may interfere with the outcomes of
SC grafts: 1) long-term increase of ROS (over 24 hours incubation
time) independently from SPIOn presence; 2) dose-dependent
impairment of migration in SPIOn loaded cells which appears
correlated to the SC type used in the study. However we also
detected a partial recovery of cell motility, dose-dependently, by a
chemoattractant (here FBS) or, time dependently, by a degener-
ative surrounding (here SH-SY5Y exposed to 6-OHDA).
Our results also suggest that SC SPIOn labeling is a promising
strategy, but requires future experiments and optimization in vivo
for its safe application to nanomedicine and nanodiagnostic,
especially for the treatment of neurodegenerative diseases.
Supporting Information
Figure S1 Representative confocal image of PKH26-
labeled hCVCs (red) and PKH67-labeled hAFCs (green)
showing comparable cell size between the two popula-
tions, thus supporting the flow cytometry data. (Figure 4).
(TIF)
File S1 This file contains Tables S1 and S2. Table S1:
Scheme of experiment for SPIOn labeling. Table S2: Experimen-
tal protocol for migration assay.
(DOC)
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